Inpharma

Antifungal resistance discussed
pp. 2-2(1)

NICE issues guidance for arthritis, non-Hodgkin's lymphoma
pp. 3-3(1)

Conjugate pneumococcal vaccines: promising but lacking evidence
pp. 3-3(1)

The global health community is not ready for the next influenza pandemic
pp. 3-3(1)

The Pretoria High Court has recently ordered the South African government to increase access to nevirapine for pregnant women with HIV infection
pp. 3-3(1)

Recently released guidelines
pp. 4-4(1)

Tacrolimus ointment cost effective in atopic dermatitis
pp. 4-4(1)

Triflusal cost saving in the treatment of acute MI
pp. 5-5(1)

Epoetin alfa: IV to SC switch cost saving?
pp. 5-5(1)

Aspirin still not used optimally in CAD
pp. 5-5(1)

Docetaxel cost effective as second-line therapy in NSCLC
pp. 5-5(1)

Continuous SC treprostinil sodium effective in pulmonary hypertension
pp. 6-6(1)

Physicians in the US are being targeted by the US CDC in an effort to prevent antibacterial resistance
pp. 6-6(1)

Cycloserine improves negative symptoms of schizophrenia
pp. 6-6(1)

Enfuvirtide: turning the tide of drug resistance in HIV?
pp. 7-8(2)

Prolonged enoxaparin sodium prophylaxis: significant benefit
pp. 9-9(1)

Trimetazidine was used successfully to treat anthracycline-induced cardiotoxicity
pp. 9-9(1)

Statins may decrease AV calcium accumulation
pp. 9-9(1)

A human papillomavirus (HPV) vaccine consisting of a vaccinia virus vector encoding HPV proteins has promising activity
pp. 9-9(1)

Use genetic screening prior to HRT?
pp. 10-10(1)

Short-burst betamethasone vs hydrocortisone in atopic eczema
pp. 10-10(1)

Epirubicin + docetaxel + G-CSF effective in breast cancer
pp. 10-10(1)

LIFE study shows superiority of losartan
pp. 11-13(3)

Nesiritide superior to nitroglycerin in decompensated CHF
pp. 13-13(1)

Evidence supports triple therapy regimens in HIV infection
pp. 14-14(1)

Eptifibatide plus alteplase is more effective than alteplase alone in acute MI
pp. 14-14(1)

There is a time-dependent benefit from aspirin in patients receiving thrombolysis for acute MI
pp. 14-14(1)

Bisoprolol improves the survival of patients with chronic heart failure
pp. 14-14(1)

Tenofovir disoproxil fumarate has durable efficacy in HIV
pp. 15-16(2)

Influenza vaccine: half- vs full-dose
pp. 16-16(1)

Vitamins inhibit transplant-associated coronary arteriosclerosis
pp. 17-17(1)

Stenting ± abciximab more effective in acute MI
pp. 18-18(1)

Pioglitazone ameliorated symptoms of asthma in two patients
pp. 18-18(1)

Nesiritide more beneficial than dobutamine in CHF
pp. 18-18(1)

Sirolimus shows inhibition of tumour growth
pp. 19-19(1)

Isoflavones reduce breast cancer risk?
pp. 19-19(1)

Tocopherol supplementation reduces markers of thrombosis
pp. 19-19(1)

Routine use of milrinone in CHF not supported
pp. 20-20(1)

Troglitazone superior to metformin in type 2 diabetes
pp. 20-20(1)

Maternal in utero diethylstilbestrol increases hypospadias in offspring
pp. 21-21(1)

Anthrax vaccination: no effect on pregnancy rates or outcome
pp. 21-21(1)

Abacavir: genetic susceptibility to hypersensitivity
pp. 21-21(1)

US market news
pp. 22-22(1)

EU market news
pp. 22-22(1)

Quetiapine [`Seroquel'; AstraZeneca] has been launched in China
pp. 22-22(1)

Long-term OC use increases cervical cancer risk in HPV-positive women
pp. 22-22(1)

Product Introductions
pp. 23-23(1)